BeamO combines electrocardiogram sensors, a stethoscope and a thermometer into a single device that patients can use at home to learn more about their health. Findings can then be submitted for a cardiologist to review.

Physicians often tell AFib patients they should limit coffee consumption to protect their hearts. This new analysis, however, suggests that may not be necessary.

Procizumab was developed to change the trajectory of shock by addressing an underlying molecular driver rather than just managing symptoms.

Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes. 

The Association of Black Cardiologists hopes to improve widespread disparities in care through the use of patient education, free diagnostic heart screenings and other proven methods. 

The WVU Heart and Vascular Institute is hosting a two-day symposium focused on exploring the benefits and long-term potential of robotic aortic valve replacement. Fans of the procedure say it represents a safe, effective alternative to TAVR and SAVR in patients with severe aortic stenosis. 

Calcium in the coronary arteries is a known cardiac risk factor. However, new data suggest it may actually tell us more about a person's overall health than researchers previously believed. 

Researchers warned that “aggressive procedural modifications” should not be necessary during TAVR to mitigate the risk of prosthesis-patient mismatch. This appears to be true for patients receiving both self-expanding and balloon-expandable TAVR valves.

The technology, developed by New Jersey-based Integra LifeSciences, is already approved for several other specialties, including neurosurgery and orthopedic surgery. 

Adults are three times as likely to have a heart attack or stroke after a COVID-19 infection than when they are healthy. The risks are even greater for the flu.

Bleeding events remain a serious complication after TAVR. By identifying high-risk patients early and planning ahead, however, care teams can keep them to a minimum.

The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.

The Munich, Germany-based company is doing so by transferring 30% of total shares in Siemens Healthineers over to the parent company’s stockholders. 

The insurer claims personal injury attorneys referred patients to the network, where they allegedly received dubious treatments and undergo excessive testing to inflate medical claims. Allstate is seeking up to $5.2 million in restitution.